Adaptin Bio APTN
OTC APTN
$6.27 +0.02 (+0.32%)
At close: Aug 3, 2026 · 4:00 PM UTC

Adaptin Bio (APTN) Other Non Operating Income (2024 - 2026)

Adaptin Bio (APTN) posted Other Non Operating Income of $326345.0 for Q1 2026, down 1.9% sequentially from $332657.0 in Q3 2025, and up 5270.23% YoY from $6076.9 in Q1 2025.

Adaptin Bio (APTN) Other Non Operating Income (2024 - 2026) Analysis & Trends

Adaptin Bio has reported Other Non Operating Income for 3 years, with the latest figure at $326345.0 in Q1 2026.

  • Quarterly Other Non Operating Income rose 5270.23% year-over-year to $326345.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $659002.0 (up 428.33% YoY) and the FY2025 annual result came in at $326345.0, up 267.75% from the prior year.
  • Other Non Operating Income retreated to $326345.0 in Q1 2026 per APTN's latest filing, from $332657.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $332657.0 in Q3 2025 and troughed at -$185782.0 in Q4 2024.
  • A 3-year average of $65450.4 and a median of -$2373.0 in 2024 frame the typical range for Other Non Operating Income.
  • The widest YoY moves for Other Non Operating Income: up 5423.36% in 2025, down 4645.86% in 2025.
  • Over 3 years, Other Non Operating Income stood at -$185782.0 in 2024, then soared by 279.06% to $332657.0 in 2025, then declined by 1.9% to $326345.0 in 2026.
  • According to Business Quant data, Other Non Operating Income over the past three periods registered $326345.0, $332657.0, and -$6312.0 for Q1 2026, Q3 2025, and Q1 2025 respectively.

Peer Comparison

Historic Data

Download Data
DateValue
Mar 31, 2026 326,345.00
Sep 30, 2025 332,657.00
Mar 31, 2025 -6,312.00
Dec 31, 2024 -185,782.00
Sep 30, 2024 -6,249.00
Jun 30, 2024 -2,373.00
Mar 31, 2024 -133.00